EA200702510A1 - Способы защиты от апоптоза с применением липопептидов - Google Patents
Способы защиты от апоптоза с применением липопептидовInfo
- Publication number
- EA200702510A1 EA200702510A1 EA200702510A EA200702510A EA200702510A1 EA 200702510 A1 EA200702510 A1 EA 200702510A1 EA 200702510 A EA200702510 A EA 200702510A EA 200702510 A EA200702510 A EA 200702510A EA 200702510 A1 EA200702510 A1 EA 200702510A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- lipopeptides
- apoptosis
- protection
- methods
- inducers
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/542—Carboxylic acids, e.g. a fatty acid or an amino acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/55—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug, i.e. a dimer, oligomer or polymer of pharmacologically or therapeutically active compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Описано применение липопептидов в качестве индукторов NF-κВ для защиты млекопитающих от действий апоптоза.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US68981005P | 2005-06-13 | 2005-06-13 | |
PCT/US2006/022865 WO2006138238A2 (en) | 2005-06-13 | 2006-06-13 | Methods of protecting against apoptosis using lipopeptides |
Publications (2)
Publication Number | Publication Date |
---|---|
EA200702510A1 true EA200702510A1 (ru) | 2008-06-30 |
EA014644B1 EA014644B1 (ru) | 2010-12-30 |
Family
ID=37571018
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200702510A EA014644B1 (ru) | 2005-06-13 | 2006-06-13 | Способы защиты от апоптоза с применением липопептидов |
Country Status (17)
Country | Link |
---|---|
US (4) | US8008260B2 (ru) |
EP (2) | EP2554181B1 (ru) |
JP (1) | JP5000644B2 (ru) |
KR (2) | KR101604799B1 (ru) |
CN (1) | CN101242852B (ru) |
AU (1) | AU2006259630B2 (ru) |
BR (1) | BRPI0611586A2 (ru) |
CA (1) | CA2612102C (ru) |
EA (1) | EA014644B1 (ru) |
ES (2) | ES2421447T3 (ru) |
HK (2) | HK1123495A1 (ru) |
IL (1) | IL188091A (ru) |
MX (1) | MX2007015834A (ru) |
NZ (1) | NZ565063A (ru) |
PT (1) | PT1904084E (ru) |
WO (1) | WO2006138238A2 (ru) |
ZA (1) | ZA200800126B (ru) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006133403A2 (en) | 2005-06-07 | 2006-12-14 | The Regents Of The University Of Colorado | Inhibitors of serine protease activity and their use in methods and compositions for treatment of graft rejection and promotion of graft survival |
US9457070B2 (en) | 2005-06-07 | 2016-10-04 | The Regents Of The University Of Colorado, A Body Corporate | Compositions, methods and uses of alpha 1-antitrypsin for early intervention in bone marrow transplantation and treatment of graft versus host disease |
AU2006259630B2 (en) * | 2005-06-13 | 2011-10-27 | Cleveland Biolabs, Inc. | Methods of protecting against apoptosis using lipopeptides |
CA2655933C (en) * | 2006-06-23 | 2014-09-09 | Alethia Biotherapeutics Inc. | Polynucleotides and polypeptide sequences involved in cancer |
CA2675032A1 (en) * | 2007-01-09 | 2008-07-17 | Cleveland Biolabs, Inc. | Methods for increasing and mobilizing hematopoietic stem cells |
WO2009074569A1 (en) * | 2007-12-11 | 2009-06-18 | Bracco International Bv | Targeting and therapeutic compounds with a polyproline-comprising spacer and gas-filled microvesicles comprising said compounds |
AU2009287339B2 (en) * | 2008-08-28 | 2015-11-26 | The University Of Queensland | Mutant bacterial glycoproteins and uses thereof |
US9150510B2 (en) * | 2008-09-18 | 2015-10-06 | Nippon Zoki Pharmaceutical Co., Ltd. | Amino acid derivative |
CA3050455A1 (en) | 2008-11-03 | 2010-06-03 | Adc Therapeutics Sa | Antibodies that specifically block the biological activity of a tumor antigen |
US8404444B2 (en) * | 2009-02-25 | 2013-03-26 | Diacarta Llc | Method for predicting the level of damage to cells by measuring free circulating Alu nucleic acid |
JP5210405B2 (ja) * | 2010-03-17 | 2013-06-12 | 日本臓器製薬株式会社 | アミノ酸誘導体を含有する医薬及び該誘導体の製造方法 |
EP2490021A1 (en) | 2011-02-18 | 2012-08-22 | Biotempt B.V. | Modulators of PRR and GPCR signalling |
EP2683398A1 (en) * | 2011-03-11 | 2014-01-15 | Omni Bio Pharmaceutical, Inc. | Compositions, methods and uses for radioprotectants |
PT3173427T (pt) | 2011-03-31 | 2019-09-17 | Adc Therapeutics Sa | Anticorpos contra antigénio associado ao rim 1 e fragmentos de ligação a antigénio dos mesmos |
DE102011018499A1 (de) * | 2011-04-23 | 2012-10-25 | Emc Microcollections Gmbh | Topische Nanopartikel-Vakzine zur Immunstimulation der dendritischen Zellen in der Haut |
NZ625758A (en) | 2012-01-09 | 2016-05-27 | Alethia Biotherapeutics Inc | Method for treating breast cancer |
JP5686841B2 (ja) * | 2013-04-26 | 2015-03-18 | フレゼニウス メディカル ケア ドイッチェランド ゲゼルシャフト ミット ベシュレンクテル ハフツング | 損傷しまたは傷害を受けた組織または臓器の内皮/上皮再生用医薬の製造のための、幹細胞由来微小胞(mv)の使用ならびにインビトロおよびインビボでの関連した方法 |
US20160287553A1 (en) | 2013-11-22 | 2016-10-06 | Deutsches Krebsforschungszentrum | Translation inhibitors in high-dose chemo- and/or high-dose radiotherapy |
WO2016073733A1 (en) * | 2014-11-06 | 2016-05-12 | Cleveland Biolabs, Inc. | Methods of treating cancer using lipopeptides |
CN112851755B (zh) * | 2021-01-13 | 2023-09-01 | 中国人民解放军军事科学院军事医学研究院 | 一种线性脂肽化合物及其制备方法与应用 |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2860893D1 (en) | 1977-06-20 | 1981-11-05 | Ciba Geigy Ag | Lipopeptides, process for their preparation and pharmaceutical compositions containing them |
US4554101A (en) | 1981-01-09 | 1985-11-19 | New York Blood Center, Inc. | Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity |
US6024964A (en) | 1985-06-24 | 2000-02-15 | Hoechst Aktiengesellschaft | Membrane anchor/active compound conjugate, its preparation and its uses |
US5192553A (en) | 1987-11-12 | 1993-03-09 | Biocyte Corporation | Isolation and preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood and methods of therapeutic use |
EP0604945A1 (en) | 1992-12-28 | 1994-07-06 | Takeda Chemical Industries, Ltd. | TAN-1511, its derivatives, production and use thereof |
AU666789B2 (en) * | 1992-12-28 | 1996-02-22 | Takeda Chemical Industries Ltd. | 2-amino-6,7-dihydroxy-4-thiaheptanoic acid derivatives, production and use thereof |
US5449761A (en) * | 1993-09-28 | 1995-09-12 | Cytogen Corporation | Metal-binding targeted polypeptide constructs |
AU1170595A (en) | 1993-11-04 | 1995-05-23 | Cytoclonal Pharmaceutics, Inc. | A fusion protein and method for making and using same |
WO1999035162A1 (en) * | 1998-01-07 | 1999-07-15 | Jenner Biotherapies, Inc. | Therapeutic liposome-encapsulated immunomodulators |
US6239119B1 (en) * | 1998-04-27 | 2001-05-29 | Medimmune Oncology, Inc. | Topical administration of amifostine and related compounds |
DE19822820A1 (de) | 1998-05-20 | 1999-11-25 | Biotechnolog Forschung Gmbh | Pharmazeutisches Präparat zur Wundbehandlung |
US20030170249A1 (en) * | 1999-02-19 | 2003-09-11 | Hakomori Sen-Itiroh | Vaccines directed to cancer-associated carbohydrate antigens |
WO2000064439A1 (en) * | 1999-04-26 | 2000-11-02 | Center For Molecular Medicine And Immunology | Use of antioxidants to mitigate radioimmunotherapy-induced radiation toxicity |
JP2003514828A (ja) * | 1999-10-27 | 2003-04-22 | セル−サイ・コーポレーシヨン | 自己免疫および移植組織に関連する宿主対移植片症状の処置に有用なペプチド構築物の調製法および組成物 |
DE10048840A1 (de) * | 2000-10-02 | 2002-04-11 | Biotechnolog Forschung Gmbh | Verwendung von Lipopeptiden oder Lipoproteinen zur Behandlung von Lungeninfektionen und -tumoren |
CN102302493B (zh) | 2001-07-31 | 2015-08-12 | 健赞股份有限公司 | 活化祖细胞/干细胞的方法 |
US20050276813A1 (en) | 2002-04-04 | 2005-12-15 | Peter Muhlradt | Use of a lipopeptide or lipoprotein as an adjuvant in therapeutic or prophylactic vaccinations |
US20030224422A1 (en) * | 2002-04-08 | 2003-12-04 | St. Jude Children's Research Hospital, Inc. | Pre-and post therapy gene expression profiling to identify drug targets |
US20040259790A1 (en) * | 2003-01-30 | 2004-12-23 | Bali Pulendran | Methods for identifying and administering agents that bias the immune response via dendritic cells |
WO2005030133A2 (en) * | 2003-09-22 | 2005-04-07 | Yale University | Treatment with agonists of toll-like receptors |
WO2005057218A2 (en) | 2003-12-02 | 2005-06-23 | Cleveland Clinic Foundation | Methods of identifying modulators of apoptosis from parasites and uses thereof |
WO2005056041A2 (en) | 2003-12-02 | 2005-06-23 | Cleveland Clinic Foundation | METHODS OF INHIBITING APOPTOSIS USING LATENT TGFβ |
US20060039895A1 (en) * | 2004-02-28 | 2006-02-23 | Large Scale Biology Corporation | Ex-vivo rescue of hematopoietic stem cells after lethal irradiation |
AU2006259630B2 (en) | 2005-06-13 | 2011-10-27 | Cleveland Biolabs, Inc. | Methods of protecting against apoptosis using lipopeptides |
CA2675032A1 (en) | 2007-01-09 | 2008-07-17 | Cleveland Biolabs, Inc. | Methods for increasing and mobilizing hematopoietic stem cells |
-
2006
- 2006-06-13 AU AU2006259630A patent/AU2006259630B2/en not_active Ceased
- 2006-06-13 EP EP20120190223 patent/EP2554181B1/en not_active Not-in-force
- 2006-06-13 ES ES06784792T patent/ES2421447T3/es active Active
- 2006-06-13 CN CN2006800293364A patent/CN101242852B/zh not_active Expired - Fee Related
- 2006-06-13 WO PCT/US2006/022865 patent/WO2006138238A2/en active Application Filing
- 2006-06-13 EP EP20060784792 patent/EP1904084B1/en not_active Not-in-force
- 2006-06-13 BR BRPI0611586-1A patent/BRPI0611586A2/pt not_active IP Right Cessation
- 2006-06-13 CA CA2612102A patent/CA2612102C/en not_active Expired - Fee Related
- 2006-06-13 EA EA200702510A patent/EA014644B1/ru not_active IP Right Cessation
- 2006-06-13 KR KR1020147004582A patent/KR101604799B1/ko not_active IP Right Cessation
- 2006-06-13 KR KR1020077029227A patent/KR20080030566A/ko active Application Filing
- 2006-06-13 MX MX2007015834A patent/MX2007015834A/es active IP Right Grant
- 2006-06-13 PT PT67847921T patent/PT1904084E/pt unknown
- 2006-06-13 US US11/917,494 patent/US8008260B2/en not_active Expired - Fee Related
- 2006-06-13 ES ES12190223.3T patent/ES2539490T3/es active Active
- 2006-06-13 NZ NZ565063A patent/NZ565063A/en not_active IP Right Cessation
- 2006-06-13 JP JP2008516988A patent/JP5000644B2/ja not_active Expired - Fee Related
-
2007
- 2007-12-12 IL IL188091A patent/IL188091A/en not_active IP Right Cessation
-
2008
- 2008-01-04 ZA ZA200800126A patent/ZA200800126B/xx unknown
-
2009
- 2009-02-04 HK HK09100988A patent/HK1123495A1/xx not_active IP Right Cessation
-
2011
- 2011-03-18 US US13/051,549 patent/US8524668B2/en not_active Expired - Fee Related
-
2013
- 2013-07-15 US US13/942,028 patent/US9006183B2/en not_active Expired - Fee Related
- 2013-08-06 HK HK13109211.9A patent/HK1181684A1/xx not_active IP Right Cessation
-
2015
- 2015-03-06 US US14/641,061 patent/US9381225B2/en active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA200702510A1 (ru) | Способы защиты от апоптоза с применением липопептидов | |
MX360301B (es) | Moleculas pequeñas que contienen boro como agentes antiinflamatorios. | |
CL2012000887A1 (es) | Mezcla fungicida sinergica que comprende fluorocitosina y otros compuestos fungicos; composicion fungicida que comprende dicha mezcla y un adyuvante agricolamente aceptable o portador. | |
CL2013000304A1 (es) | Compuestos derivados de 2-arilamino-bencimidazoles inhibidores de prostaglandina e2 (mpges-1); composicion farmaceutica que los comprende; compuestos intermediarios; uso en el tratamiento de enfermedades inflamatorias y/o afecciones asociadas, en particular el dolor. | |
CO6190510A2 (es) | Inhibidores del virus de la hepatitis c | |
MA33803B1 (fr) | Inhibiteur de bromodomaine de benzodiazépine | |
SG10201809390QA (en) | Modulators of indoleamine 2,3-dioxygenase and methods of using the same | |
EA200870415A1 (ru) | Хиназолины для ингибирования pdk 1 | |
ECSP10010722A (es) | Compuestos orgánicos | |
CY1115852T1 (el) | Φαρμακευτικες συνθεσεις | |
EA200970737A1 (ru) | Оксабициклогептаны и оксабициклогептены, их получение и применение | |
BRPI1015043A2 (pt) | derivados de diazahomoadamantano e métodos de uso dos mesmos | |
BR112012014082A2 (pt) | composições e métodos que compreendem variantes de protease | |
UY33616A (es) | Compuestos con estructura de imidazotriazinona | |
CL2012001821A1 (es) | Compuestos derivados de 5-alquinil-pirimidinas, inhibidores de quinasas; composiciones farmaceuticas que los contienen; y su uso para el tratamiento y/o prevencion de cancer, infecciones, enfermedades inflamatorias y autoinmunitarias. | |
CL2011000691A1 (es) | Compuestos derivados de nicotinamida sustituida; composicion farmaceutica que los comprende; uso para el tratamiento y/o prevencion de cancer, infecciones, enfermedades inflamatorias y autoinmunitarias. | |
NO20090596L (no) | Antivirale fosfinatforbindelser | |
EA201170288A1 (ru) | Оксабициклогептаны и оксабициклогептены, их получение и применение | |
HK1133642A1 (en) | Azaadamantane ester and carbamate derivatives and methods of use thereof | |
EP2557919A4 (en) | STABILIZED FORMULATIONS OF STATIN | |
EA200601079A1 (ru) | Способы защиты от радиации с использованием флагеллина | |
CY1109992T1 (el) | Παραγωγα του αλφα-αμιναμιδιου χρησιμα ως αντιφλεγμονωδη μεσα | |
SG158091A1 (en) | Imidazoazepinone compounds | |
PA8630801A1 (es) | Nuevos imidazoles | |
EA201170201A1 (ru) | Предотвращение и лечение радиационного поражения |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
TK4A | Corrections in published eurasian patents | ||
PC4A | Registration of transfer of a eurasian patent by assignment | ||
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ KG MD TJ TM |
|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): BY KZ RU |